Mersana Therapeutics Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $6.28 on 03/11/24, and the lowest price during that time was $1.22, recorded on 08/14/24.
52-week price history of MRSN Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Mersana Therapeutics Inc’s current trading price is -65.45% away from its 52-week high, while its distance from the 52-week low is 77.87%. The stock’s price range during this period has fluctuated between $1.22 and $6.28. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 3.09 million for the day, which was evidently higher than the average daily volume of 1.03 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Mersana Therapeutics Inc (MRSN) has experienced a quarterly rise of 45.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 268.07M and boasts a workforce of 123 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.90, with a change in price of +0.29. Similarly, Mersana Therapeutics Inc recorded 1,127,630 in trading volume during the last 100 days, posting a change of +15.43%.
MRSN Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MRSN stands at 30.00. Similarly, the long-term debt-to-equity ratio is also 15.51.
MRSN Stock Stochastic Average
The raw stochastic average for Mersana Therapeutics Inc over the last 50 days is presently at 37.44%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 35.92%. Further, the company’s Stochastic %K and %D values for the last 20 days were 26.21% and 24.49%, respectively.
MRSN Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price decrease of -6.47%. However, over the past six months, we’ve seen a stronger performance of -7.66%. The price of MRSN fallen by 6.37% over the last 30 days. And in the last five days, it has fallen by -2.25%.
